Urinary Sulphated Glycosaminoglycans and Tamm-Horsfall Protein in Type 1 Diabetic Patients

REFERENCES

• Van den Born J, van Kraats AA, Bakker MAH, Assmann KJM, van den Heuvel LPWJ, Veerkamp JH, et al. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. Diabetologia 1995; 38: 161–72.
   PubMed Web of Science ®Google Scholar
• Tamsma JT, Van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994; 37: 313–20.
   PubMed Web of Science ®Google Scholar
• Van den Born J, van Kraats AA, Bakker MAH, Assmann KJM, Dijkman HBPM, van der Laak JAWM, et al. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin induced diabetic nephropathy. Diabetologia 1995; 38: 1169–75.
   PubMed Web of Science ®Google Scholar
• Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N. Enalapril improves albuminuria by preventing glomerular loss of heparan sulphate in diabetic rats. Biochem Med Metab Biol 1991; 45: 119–31.
   Google Scholar
• Parthasarathy N, Spiro RG. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 1982; 31: 738–41.
   PubMed Web of Science ®Google Scholar
• Wu V-Y, Wilson B, Cohen MP. Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes. Diabetes 1987; 36: 679–83.
   PubMedGoogle Scholar
• Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM. Heparan sulphate proteoglycan in the glomerular base-ment membrane in type 1 diabetes mellitus. Kidney Int 1992; 41: 1070–80.
   Google Scholar
• Seiler MW, Rennke HG, Venkatachalam MA, Cotran RS. Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest 1977; 36: 48–61.
   PubMed Web of Science ®Google Scholar
• Rosenzweig LJ, Kanwar YS. Removal of sulphated (heparan sulphate) or nonsulphated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab Invest 1982; 47: 177–84.
   PubMed Web of Science ®Google Scholar
• Rasch R, Torffvit O, Bachmann S, Jensen PK, Jacobsen NO. Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion. Diabeto-logia 1995; 38: 525–35.
   Google Scholar
• Torffvit O, Agardh C-D. Urinary excretion rate of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient. J Diab Comp 1994; 8: 77–83.
   Google Scholar
• Torffvit O, Jorgensen PE, Kamper A-L, Holstein-Rathlou N-H, Leyssac PP, Poulsen SS, et al. Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron 1998; 79: 167–72.
   Google Scholar
• Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycos-aminoglycans in connective tissue. Nature 1984; 307: 650–2.
   PubMed Web of Science ®Google Scholar
• Tencer J, Torffvit O, Bj(imsson S, Thysell H, Grubb A, Rippe B. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases. Clin Nephrol 1997; 48: 212–9.
   Google Scholar
• Torffvit O, Wie slander J. A simplified enzyme-linked immunosorbent assay for urinary albumin. Scand J Clin Lab Invest 1986; 46: 545–8.
   PubMed Web of Science ®Google Scholar
• Torffvit O, Agardh C-D, Kjellsson B, Wieslander J. Tubular secretion of Tamm-Horsfall protein in type 1 (insulin-dependent) diabetes mellitus using a simplified enzyme linked immunoassay. Clin Chim Acta 1992; 205: 31–41.
   Google Scholar
• Makino H, Ikeda S. Haramoto T, Ota Z. Heparan sulphate proteoglycans are lost in patients with diabetic nephropathy. Nephron 1992; 61: 415–21.
   PubMed Web of Science ®Google Scholar
• Wessler E. The nature of the non-ultrafilterable glycosaminoglycans of normal human urine. Biochem J 1971; 122: 373–84.
   PubMed Web of Science ®Google Scholar
• Sindelka G, Skrha J, Stibor V. Stolba P. Glycos-aminoglycans in urine of type 1 diabetic patients. Sbomik Lekarsky 1993; 94: 77–80.
   Google Scholar
• Hansen Ch, Irmscher AK, Kuhlemann K, Beyer J, Kahaly G. Insulin-dependent diabetes mellitus and glycosaminoglycans. Horm Metab Res 1955; 27: 555–8.
   Google Scholar
• McAuliffe AV, Fisher EJ, McLennan SV, Yue DK, Turtle JR. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminuria. Diabetic Med 1996; 13: 758–63.
   Google Scholar
• Priestly GC, Collier A, Matthews DM, Clarke BF. Increased urinary excretion of glycosaminoglycans in insulin-dependent diabetic patients with limited joint mobility. Br J Rheumatol 1988; 27: 462–4.
   PubMedGoogle Scholar
• Mahadevan P. Larkins RG, Fraser JRE, Fosang AJ, Dunlop ME. Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia 1995; 38: 298–305.
   Google Scholar
• Bedir A, Ozener IC, Adam B, Emerk K. Utility of glomerular and tubular markers in establishing early renal involvement in type II diabetes mellitus. Clin Biochem 1996; 29: 385–8.
   PubMed Web of Science ®Google Scholar
• Myrup B, Hansen PM, Jensen T, Kofoed-Enevoldsen A, Feldt-Rasmussen B, Gram J, et al. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 1995; 345: 421–2.
   Google Scholar
• Solini A, Ricci F, Vergnani L, Crepaldi G. Glycos-aminoglycans delay the progression of nephropathy in NIDDM. Diabetes Care 1997; 20: 819–23.
   PubMed Web of Science ®Google Scholar
• Jyothirmayi G, Reddi AS. Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats. Hypertension 1993; 21: 795–802.
   PubMed Web of Science ®Google Scholar